Overview

Stage I Multiple Myeloma Treatment

Status:
Unknown status

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

- Assessment of survival without progression of stage I MM in two groups: arm A: simple survey and arm B: administration of Zoledronate. - Describe different progression's type noticed and define the prognosis factors of a fast evolution.

Phase:

Phase 4

Details

Lead Sponsor:

Centre Hospitalier Universitaire de Nice

Treatments:

Zoledronic Acid